About IDDI
We are an expert clinical data services and high-level strategic consulting contract research organization (CRO), providing agile clinical trials services for pharmaceutical, biotech, and medical device/diagnostic companies.
With a proven track record, IDDI provides expert Biostatistics and eClinical Services to ensure the successful execution of your clinical development program.
Passion. Science. Experience.
A passionate and experienced science-led team, committed to delivering submission-ready clinical data.
Meet Our TeamCommitment to Quality and Precision
“IDDI was of great benefit, particularly with respect to their responsiveness, their commitment to quality and precision, and their ability to meet our very ambitious timelines.”
Jim Taylor, CEO Oraya Therapeutics, Newark, CA, USA
How IDDI Adds Value to Your Clinical Data
Strategic-level consultancy to optimize your clinical development program even in clinical trials with complex settings.
Delivered by talented, forward-thinking and science-led professionals, who will take ownership of your needs.
Over 30 years in business ensuring continuity in your clinical development.
IDDI’s culture is scientifically driven, thanks to its founder and Chief Scientific Officer, Marc Buyse, CEO.
Expert clinical data services (EDC/RTSM/Medical Coding) providing flexible solutions for collection, standardization, analysis, documentation and reporting of your clinical data.
A Project Manager is assigned to every project. Flexibility, responsiveness, proactiveness are skills often mentioned by our customers.
Experienced contract research organization with a solid understanding of the clinical development process and breadth of therapeutic areas expertise.
Thanks to a strong collaborative approach with Academics and Key Opinion Leaders.
Resource Library
Discover our on-demand recorded webinars, podcasts, videos and scientific articles.
Videos ›
Webinars ›
Podcasts ›
Scientific Articles ›
Brochures ›
Fast growing company – Rewarding career. Join us and contribute to the progress of clinical research. An inspiring and exciting career with international and challenging projects is waiting for you!
Join UsOctober 21, 2021
Webinar: Phase I trials in oncology: Pros and cons of current designs
Demystifying different types of Bayesian and frequentist designs that may be used for first-in-human or other types of phase I…
View WebinarIDDI sponsors the 2nd Annual Dry AMD Therapeutic Development Summit
IDDI is a proud sponsor of the 2nd Annual Dry AMD Therapeutic Development Summit! Schedule a meeting with our BD…
IDDI at Outsourcing in Clinical Trials and Clinical Trials Supply Nordics 2021
Meet IDDI team at Booth #25 and get a chance to win a Bose® Sport Earbuds set! FILL IN THE…
Webinar: Phase I trials in oncology: Pros and cons of current designs
Demystifying different types of Bayesian and frequentist designs that may be used for first-in-human or other types of phase I…
IDDI at BeCRO CRO vs Pharma/Biotech/MD battle event
Join IDDI at the BeCRO CRO-Sponsor Battle on October 26 What you never dared to ask when you are contracted…
IDDI at OIS Retina Innovation Summit 2021
IDDI team will be attending the OIS Retina Innovation Summit 2021! The OIS Retina Innovation Summit gathers leaders from across…
IDDI at HealthTech Innovation Days 2021
Join IDDI at the HealthTech Innovation Days 2021 in Paris this October 4-5 IDDI will be present at the HealthTech…
SCRIP Awards
IDDI selected as a finalist for the Best Contract Research Organization – Specialist Providers category. We’re so excited to be recognized…
ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop
Statistics in the Changing Product-Development Environment Accelerated by the Pandemic Marc Buyse, ScD speaker at the plenary session: Statistics in…
Sample Size Re-Estimation as an Adaptive Design
Using the promising-zone approach can salvage an underpowered trial. Sample size Re-estimation (SSRE) is a relatively new concept, but, thanks…
IDDI Sponsor at Gene Therapy for Ophthalmic Disorders Digital Conference
Join IDDI at the 2nd Gene Therapy for Ophthalmic Disorders Digital meeting. It will target the industry’s translational challenges in targeting…